BL Nanobiomed offers integrated and customized solutions for the development of the novel nanomaterials (drug delivery nanosystems, nanoparticles, scaffolds and nanocoatings) processes, equipment and quality control tools that can be efficiently combined for improved implants performance.
…for the Constant release of anti-inflammatory, anti-restenotic, anti-thrombotic Drugs to overcome Stent complications and promote tissue regeneration.
…that guarantee a Sustained Release of anti-inflammatory drugs or antibiotics from orthopedic implants & surgical tools.
…for the sustained Intraocular release of anti-inflammatory drugs after cataract surgery.
Nanoporous multifunctional materials for drug delivery
What can we achieve with the engineered Drug Eluting Nanosystems?
A) Controllable, targeted and sustainable drug release at the diseased site for optimized effectiveness
B) Customer-made design to meet the requirements for each medical application
C) Delivery of different drugs even insoluble ones
D) Minimized toxicity due to their full biodegradability and no permanent presence in the human body
E) Application to a wide range of implants and biomedical devices (e.g. cardiovascular, orthopedic, surgical, neurological implants, lens, patches, etc)
…Such systems will form the basic components of highly added value medical products designed to diagnose and treat human diseases.
|Theranostic Biodegradable Nanoparticles|
…for Targeted Diagnostic and Therapeutic Activities
|Scaffolds for Drug Delivery and Tissue Regeneration|
…for Sustained and Controllable Drug Release and Tissue Regeneration
|Tissue Engineered Implants|
Nanofibers onto stents that release anti-inflammatory drugs and promote stent endothelialization to avoid stent thrombosis and restenosis